Synthesis, characterization and in vitro cytotoxicity of the first palladium(II) oxalato complexes involving adenine-based ligands

The first [Pd(Lⁿ)₂(ox)] xH₂O oxalato(ox) complexes involving 2-chloro-N6-(benzyl)-9-isopropyladenine (L¹; complex 1), 2-chloro-N6-(4-methoxybenzyl)-9-isopropyladenine (L²; 2), 2-chloro-N6-(2,3-dimethoxybenzyl)-9-isopropyladenine (L³; 3), 2-chloro-N6-(2,4-dimethoxybenzyl)-9-isopropyladenine (L⁴; 4), and 2-chloro-N6-(4-methylbenzyl)-9-isopropyladenine (L⁵; 5) have been synthesized by the reactions of potassium bis(oxalato)palladate(II) dihydrate, [K₂Pd(ox)₂]·2H₂O, with the mentioned organic compounds (H₂ox = oxalic acid; x = 0 for 1-3 and 5 or 2 for 4). Elemental analyses (C, H, N), FTIR, Raman and NMR (¹H, ¹³C, ¹⁵N) spectroscopies, conductivity measurements and thermal studies (thermogravimetric and differential thermal analyses, TG/DTA) have been used to characterize the prepared complexes. The molecular structures of [Pd(L²)₂(ox)] (2) and [Pd(L⁵)₂(ox)]·L⁵·Me₂CO (5·L⁵·Me₂CO) have been determined by a single crystal X-ray analysis. The geometry of these complexes is slightly distorted square-planar with two appropriate Lⁿ (n = 2 or 5) molecules mutually arranged in the head-to-head (2) or head-to-tail (5) orientation. The Lⁿ ligands are coordinated to the central Pd(II) ion via the N7 atoms. The same conclusions regarding the binding properties of L¹-L⁵ ligands can be made based on multinuclear NMR spectra. In vitro cytotoxicity of the complexes 1-5 has been evaluated against human chronic myelogenous leukaemia (K562) and human breast adenocarcinoma (MCF7) cancer cell lines. Significant cytotoxicity has been determined for the complexes 3 (IC₅₀ = 6.2 μM) and 5 (IC₅₀ = 6.8 μM) on the MCF7 cell line, which is even better than that found for the well-known and widely-used platinum-bearing antineoplastic drugs, i.e. oxaliplatin and cisplatin.     

Palladium(II) oxalato complexes involving N6-(benzyl)-9-isopropyladenine-based N-donor carrier ligands: Synthesis, general properties, H, C and N{H} NMR characterization and in vitro cytotoxicity

Reactions of potassium bis(oxalato)palladate dihydrate, K₂[Pd(ox)₂]·2H₂O, with two molar equivalents of N6-(benzyl)-9-isopropyladenine-based organic molecules (L_1-7), i.e. 2-chloro-N6-(2-methoxybenzyl)-9-isopropyladenine (L₁), 2-chloro-N6-(3-methoxybenzyl)-9-isopropyladenine (L₂), 2-chloro-N6-(3,5-dimethoxybenzyl)-9-isopropyladenine (L₃), 2-(1-ethyl-2-hydroxyethylamino)-N6-(benzyl)-9-isopropyladenine (L₄), 2-(1-ethyl-2-hydroxyethylamino)-N6-(2-methoxybenzyl)-9-isopropyladenine (L₅), 2-(1-ethyl-2-hydroxyethylamino)-N6-(3-methoxybenzyl)-9-isopropyladenine (L₆) and 2-(1-ethyl-2-hydroxyethylamino)-N6-(4-methoxybenzyl)-9-isopropyladenine (L₇), provided a series of seven palladium(II) oxalato (ox) complexes of the general formula [Pd(ox)(L_1-7)₂]·nH₂O (1-7; n = 0 for 4, 5 and 7, ¾ for 1 and 2, 1 for 6, and 3 for 3). The compounds were characterized by elemental analysis, IR, Raman, ¹H, ¹³C and ¹⁵N{¹H} NMR spectroscopy, ESI+ mass spectrometry, molar conductivity and TG/DTA thermal analysis. The geometry of [Pd(ox)(L₂)₂] (2) was optimized on the B3LYP/6-311G∗/LANL2DZ level of theory. The complexes 4-7 represent the first palladium(II) oxalato complexes with a PdN₂O₂ donor set, which involve highly potent purine-based cyclin-dependent kinase (CDK) inhibitors (L_4-7) as carrier N-donor ligands. The selected complexes 1, 3-5 and 7 were tested by an MTT assay for their in vitro cytotoxic activity against human osteosarcoma (HOS) cancer cell line. The highest activity was found for the complexes 5 (IC₅₀ = 34.9 μM) and 7 (IC₅₀ = 39.2 μM).     

Novel long bipyridine-type linking ligands containing an intervening naphthalene fragment: [Zn(L)(NO3)2], [Zn(L)(NO3)2], and [Cd(L)1.5(NO3)2] (L = (4-py)-CHN-C10H6-NCH-(4-py); L = (3-py)-CHN-C10H6-NCH-(3-py))

Novel bipyridine-type linking ligands L¹ ((4-py)-CHN-C₁₀H₆-NCH-(4-py)) and L² ((3-py)-CHN-C₁₀H₆-NCH-(3-py)), a pair of isomers due to possessing different pairs of terminal pyridyl groups, were prepared by the Schiff-base condensation. In ligand L¹, the N?N separation between the terminal pyridyl groups is 16.0 Å, with their nitrogen donor atoms at the para positions (4,4′). The corresponding N?N separation in ligand L² is 14.2 Å, with the nitrogen donor atoms at the meta positions (3,3′). 1-D zigzag-chain coordination polymers [Zn(L¹)(NO₃)₂] (1) and [Zn(L²)(NO₃)₂] (2) were prepared by reactions of Zn(NO₃)₂ · 6H₂O with ligands L¹ and L², respectively, by solution diffusion. Polymer 3, [Cd(L¹)_1.5(NO₃)₂], prepared from Cd(NO₃)₂ · 4H₂O and L¹, exhibits a 1-D ladder structure, whose repeating ladder unit consists of four Cd metals and four L¹ ligands to create a large 76-membered ring with dimensions of 20.8 × 20.8 Å. All products were structurally characterized by X-ray diffraction.     

Bis(O2S2 macrocycle) complexes of palladium(II)

Two isomeric dibenzo-O₂S₂ macrocycles L¹ and L² have been synthesised and their coordination chemistry towards palladium(II) has been investigated. Two-step approaches via reactions of 1:1-type complexes, [cis-Cl₂LPd] (1a: L = L¹, 1b: L = L²), with different O₂S₂ macrocycle systems (L¹ and L²) have led to the isolation of the following bis(O₂S₂ macrocycle) palladium(II) complexes in the solid state: [Pd(L¹)₂](ClO₄)₂ (2a) and a mixture of [Pd(L¹)₂](ClO₄)₂ (2a) + [Pd(L²)₂](ClO₄)₂ (2b).     

Reaction of [MCl2(CH3CN)2] (M = Pd(II), Pt(II)) compounds with N1-alkylpyridylpyrazole-derived ligands

Palladium(II) and platinum(II) complexes with N-alkylpyridylpyrazole-derived ligands, 2-(1-ethyl-5-phenyl-1H-pyrazol-3-yl)pyridine (L¹) and 2-(1-octyl-5-phenyl-1H-pyrazol-3-yl)pyridine (L²), cis-[MCl₂(L)] (M = Pd(II), Pt(II)), have been synthesised. Treatment of [PdCl₂(L)] (L = L¹, L²) with excess of ligand (L¹, L²), pyridine (py) or triphenylphosphine (PPh₃) in the presence of AgBF₄ and NaBPh₄ produced the following complexes: [Pd(L)₂](BPh₄)₂, [Pd(L)(py)₂](BPh₄)₂ and [Pd(L)(PPh₃)₂](BPh₄)₂. All complexes have been characterised by elemental analyses, conductivity, IR and NMR spectroscopies. The crystal structures of cis-[PdCl₂(L²)] (2) and cis-[PtCl₂(L¹)] (3) were determined by a single crystal X-ray diffraction method. In both complexes, the metal atom is coordinated by one pyrazole nitrogen, one pyridine nitrogen and two chlorine atoms in a distorted square-planar geometry. In complex 3, π-π stacking between pairs of molecules is observed.     

Zinc(II) chlorido complexes of protonated kinetin and its derivatives: Synthesis, properties and X-ray structure of [Zn(Hkinetin)Cl3]·kinetin

The syntheses and characterization of five novel zinc(II) complexes with protonated kinetin (6-furfurylaminopurine) and its derivatives are described. Based on the results following from elemental analyses (C, H, N), FTIR, Raman, ¹H and ¹³C NMR spectroscopy, conductivity measurements, thermogravimetric (TG) and differential thermal analyses (DTA), and single crystal X-ray analysis, the complexes of the general composition [Zn(HLⁿ)Cl₃]·xLⁿ (1-5) have been prepared, where L¹ = kinetin (6-furfurylaminopurine), L² = 6-(5-methylfurfurylamino)purine, L³ = 2-chloro-6-furfurylaminopurine, L⁴ = 2-chloro-6-(5-methylfurfurylamino)purine and L⁵ = 2-chloro-6-furfurylamino-9-isopropylpurine, and x = 1/2-2. The structure of [Zn(HL¹)Cl₃]·L¹ (1) has been determined by single crystal X-ray analysis. The Zn(II) atom is tetrahedrally coordinated by three chlorido ligands and one N3-protonated organic molecule forming a ZnCl₃N donor set. The organic ligand L¹ is coordinated to the Zn(II) centre through the N7 atom of the purine moiety. NMR spectroscopic study confirmed the N3 and N7 atom to be the protonation, and coordination site, respectively.     

Synthesis and characterization of isopropylamine complexes of lanthanide(II) diiodides: Molecular structure of TmI2(PrNH2)4 and EuI2(PrNH2)4

It was found that the lanthanide diiodides LnI₂ (1) (Ln = Nd, Sm, Eu, Dy, Tm, Yb) are dissolved in isopropylamine (IPA) without redox transformations. Stability of the formed solutions decreases in a row Eu ≈ Yb > Sm > Tm > Dy > Nd. Removing of a solvent in vacuum leaves complexes LnI₂(IPA)_x (2) (Nd, x = 5; Sm, Eu, Dy, Tm, Yb, x = 4) as crystalline colored solids. Stability of 2-Nd,Dy,Tm is higher than that of known THF or DME coordinated salts. Divalent state of metal in the products is confirmed by data of UV-Vis spectroscopy, magnetic measurements and their chemical behavior. Structure of 2-Eu and 2-Tm was established by X-ray diffraction analysis. Oxidation of 2-Nd,Dy in IPA affords amine-amides (PrⁱNH)Ln(IPA)_y (3) (Nd, y = 4; Dy, x = 3). n-Propylamine also dissolves the iodides 1-Sm,Eu,Dy,Tm,Yb but stability of the solutions is significantly lower. 1-Nd vigorously reacts with PrⁿNH₂ even at −30 °C which hampers the formation of the solution.     

Carboxy-derived (tpy)2Ru complexes as sub-units in supramolecular architectures: The solubilized ligand 4′-(4-carboxyphenyl)-4,4″-di-(tert-butyl)tpy and its homoleptic Ru(II) complex

We herein describe the synthesis and characterization of a series of homoleptic, Ru(II) complexes bearing peripheral carboxylic acid functionality based upon the novel ligand 4′-(4-carboxyphenyl)-4,4″-di-(tert-butyl)tpy (L₁), as well as 4′-(4-carboxyphenyl)tpy (L₂) and 4′-(carboxy)tpy (L₃) (where tpy = 2,2′: 6′,2″-terpyridine). Inspection of the metal-based oxidations (E_1/2 = 1.22-1.42 V) indicates an anodic shift (∼0.2 V) for (L₃)₂Ru²⁺ (3b) (E_1/2 = 1.40 V) relative to (L₂)₂Ru²⁺ (2b) (E_1/2 = 1.22 V). The metal-based oxidation (E_1/2 = 1.22 V) and ligand-based reductions (E_1/2 = −1.25 to −1.52 V) of (L₁)₂Ru²⁺ (1) are essentially invariant relative to those of the structural analogue 2b (PF₆)₂, which suggests no significant electronic effect caused by the tert-butyl groups. This is supported by invariance in the metal-to-ligand charge transfer bands in both the electronic absorption (494-489 nm) and emission spectra (654-652 nm). However, contrary to 2b, complex 1 is both very soluble and exhibits a highly porous solid-state structure with internal cavity dimensions of 15 Å × 14 Å due to the preclusion of inter-annular interactions by the bulky tert-butyl substituents.     

Analysis of the main structural trends for biscyclometalated dinuclear rhodium compounds of general formula Rh2(O2CR)2(PC)2 · 2H2O

A new series of biscyclometalated dinuclear rhodium (II) compounds with the general formula Rh₂(O₂CR)₂(PC)₂ · 2H₂O, being PC = (C₆H₄)P(C₆H₅)₂, R = CH₃ (1 · 2H₂O), PC = [(p-CH₃ OC₆H₃)P(p-CH₃ OC₆H₄)₂], R = CF₃ (2 · 2H₂O), PC = (C₆H₄)P[CH(CH₃)₂]₂, R = CH₃ (3 · 2H₂O) and PC = (C₆H₄)P(C₆H₅)₂, R = C₆F₅ (4 · 2H₂O) has been obtained. The crystal structures for these compounds have been determined by X-ray diffraction and the main structural trends, bond lengths, bond angles and torsion angles have been analyzed, and have also been compared with the structural parameters for different analogous complexes described previously in the literature.     

One-pot syntheses of alkenyl-phosphonio complexes of ruthenium(II), rhodium(III) and iridium(III) bearing p-cymene or pentamethylcyclopentadienyl groups

Reaction of [(p-cymene)RuCl₂(PPh₃)] (1) or [Cp^∗MCl₂(PPh₃)] (Cp^∗ = C₅Me₅) (3a: M = Rh; 4a: M = Ir) with 1-alkynes and PPh₃ were carried out in the presence of KPF₆, generating the corresponding alkenyl-phosphonio complexes, [(p-cymene)RuCl(PPh₃){CHCR(PPh₃)}](PF₆) (2a: R = Ph; 2b: R = p-tolyl) or [Cp^∗MCl(PPh₃){CHCPh(PPh₃)}](PF₆) (5: M = Rh; 6: M = Ir). Similar reactions of complexes [Cp^∗RhCl₂(L¹)] (3a: L¹ = PPh₃; 3c: L¹ = P(OMe)₃) with L² (L² = PPh₃, PMePh₂, P(OMe)₃) gave [Cp^∗RhCl(L¹)(L²)](PF₆) (7bb: L¹ = L² = PMePh₂; 7ca: L¹ = P(OMe)₃, L² = PPh₃; 7cc: L¹ = L² = P(OMe)₃). Alkenyl-phosphonio complex 5 was treated with P(OMe)₃ or 2,6-xylyl isocyanide, affording [Cp^∗RhCl(L){CHCPh(PPh₃)}](PF₆) (8a: L = P(OMe)₃; 8b: L = 2,6-xylNC). X-ray structural analyses of 2a, 6 and 8a revealed that the phosphonium moiety bonded to the C_β atom of the alkenyl group are E configuration.     

Pd(II) complexes containing N-alkyl-3-pyridine-5-trifluoromethyl pyrazole ligands: Synthesis, NMR studies and X-ray crystal structures

Palladium [PdCl₂(L)] complexes with N-alkylpyridylpyrazole derived ligands [2-(5-trifluoromethyl-1H-pyrazol-3-yl)pyridine (L¹), 2-(1-ethyl-5-trifluoromethyl-1H-pyrazol-3-yl)pyridine (L²), 2-(1-octyl-5-trifluoromethyl-1H-pyrazol-3-yl)pyridine (L³), and 2-(3-pyridin-2-yl-5-trifluoromethyl-pyrazol-1-yl)ethanol (L⁴) were synthesised. The crystal and molecular structures of [PdCl₂(L)] (L = L², L³, L⁴) were resolved by X-ray diffraction, and consist of monomeric cis-[PdCl₂(L)] molecules. The palladium centre has a typical square-planar geometry, with a slight tetrahedral distortion. The tetra-coordinate metal atom is bonded to one pyridinic nitrogen, one pyrazolic nitrogen and two chlorine ligands in cis disposition. Reaction of L (L², L⁴) with [Pd(CH₃CN)₄](BF₄)₂, in the ratio 1M:2L, gave complexes [Pd(L)]₂(BF₄)₂. Treatment of [PdCl₂(L)] (L = L², L⁴) with NaBF₄ and pyridine (py) and treatment of the same complexes with AgBF₄ and triphenylphosphine (PPh₃) yielded [Pd(L)(py)₂](BF₄)₂ and [Pd(L)(PPh₃)₂](BF₄)₂ complexes, respectively. Finally, reaction of [PdCl₂(L⁴)] with 1 equiv of AgBF₄ yields [PdCl(L⁴)](BF₄).     

Antisymbiosis. Preferential coordination of anionic oxygen versus neutral sulfur donor atoms of methylsulfanyl- or methylsulfinyl-acetato, 2-benzoato and 2-phenolato to the cis-Pt(PPh3)2 and Pt(dppe) residues

The interaction of an excess of the title ligands L⁻ with the cis-Pt(phos)₂ moieties gives compounds a-bcis-[Pt(L-O)₂(phos)₂] (a, phos = P(Ph)₃; b, phos = 1/2 dppe), in which O- is preferred to S-coordination. Such preference is confirmed by the fact that the same products are obtained by reaction of excess of L⁻ with the previously reported a-d complexes [Pt(L-O,S)(phos)₂]⁺, (c, phos = PPh₃, d, phos = 1/2 dppe), for which chelate ring opening occurs with rupture of Pt-S rather than Pt-O bonds. Compound a can be obtained also by oxidative addition of HL to [Pt(PPh₃)₃]. The Pt-O bonds in compounds a-d are stable towards substitution by Me₂SO, pyridine and tetramethylthiourea. Substitution of L’s occurs with N,N′-diethyldithiocarbamate, which forms a very stable chelate with Pt(II). Thiourea and N,N′-dimethylthiourea also react, because they give rise to cyclometallated products [Pt(phos)₂(NRC(S)NHR)]⁺ (R = H, CH₃), with one ionised thioamido group, as revealed by an X-ray investigation of [Pt(PPh₃)₂(NHC(S)NH₂)]⁺. The preference of O versus S coordination, as well as the stability of the Pt-O bonds, are discussed in terms of antisymbiosis.     

Pyridine and phosphine reactions with [CPh3][B(C6F5)4]

Trityl borate salts [4-RPyCPh₃][B(C₆F₅)₄] (R = H 1, ^tBu 2, Et 3, NMe₂4) and [R₃PCPh₃][B(C₆F₅)₄] (R = Me 5, ⁿBu 6, Ph[1] 7, p-MeC₆H₄8) are readily prepared via equimolar reaction of the appropriate pyridine or phosphine and trityl borate [CPh₃][B(C₆F₅)₄]. The analogous reactions of PⁱPr₃ affords the product [(p-ⁱPr₃P-C₆H₄)Ph₂CH][B(C₆F₅)₄] (9) while the corresponding reactions of Cy₃P and ^tBu₃P gave the cyclohexadienyl derivatives [(p-R₃PC₆H₅)CPh₂][B(C₆F₅)₄] (R = Cy 10, ^tBu 11). X-ray structures of 5 and 9 are reported.     

8-Quinolinolato complexes of ruthenium(II) and (III)

Reduction of RuQ₃ (1a, Q = 8-quinolinolato) with Zn/Hg in the presence of various π-acceptor ligands in ethanol affords RuQ₂L₂ (L₂ = (dimethylsulfoxide)₂ (2); (4-picoline)₂ (3); N,N′-dimethyl-1,4-diazabuta-1,3-diene, dab (4); cyclooctadiene, COD (5); norborna-2,5-diene, nbd (6)). Compound 6 is isolated as an equimolar mixture of cis,trans (6a) and trans,cis (6b) isomers, which can be separated by column chromatography. DFT calculations have been performed on 6a and 6b. Oxidation of 3 and 6b affords the corresponding ruthenium(III) species 7 and 8, respectively. The structures of 2, 3, 4 and 6 have been determined by X-ray crystallography.     

Half-sandwich ruthenium thiocarbonate complexes: Structures of CpRu(PPh3)2SCO2Bu, CpRu(dppe)SCO2Bu and CpRu(PPh3)(CO)SCO2Bu

Thiocarbonate ruthenium complexes of the form CpRu(L)(L′)SCO₂R (L = L′ = PPh₃ (1), 1/2 dppe (2), L = PPh₃, L′ = CO (3); R = Et (a), Buⁿ (b), C₆H₅ (c), 4-C₆H₄NO₂ (d)) have been synthesized by the reaction of the corresponding sulfhydryl complexes, CpRu(L)(L′)SH, with chloroformates, ROCOCl, at low temperature. The bis(triphenylphosphine) complexes 1 can be converted to 3 under CO atmosphere. The crystal structures of CpRu(PPh₃)₂SCO₂Buⁿ (1b), CpRu(dppe)SCO₂Buⁿ (2b), and CpRu(PPh₃)(CO)SCO₂Buⁿ (3b) are reported.     

Complexes of N-thiophosphorylthioureas RNHC(S)NHP(S)(OiPr)2 (HL) (R = pyridin-2-yl, pyridin-3-yl, 6-amino-pyridin-2-yl) with copper(I): Crystal structures of Cu(PPh3)nL (n = 1, 2)

Reaction of the potassium salts of N-thiophosphorylated thioureas of common formula RNHC(S)NHP(S)(OiPr)₂ [R = pyridin-2-yl (HL^a), pyridin-3-yl (HL^b), 6-amino-pyridin-2-yl (HL^c)] with Cu(PPh₃)₃I in aqueous EtOH/CH₂Cl₂ leads to mononuclear [Cu(PPh₃)₂L^a,b-S,S′] (1, 2) and [Cu(PPh₃)L^c-S,S′] (3) complexes. Using copper(I) iodide instead of Cu(PPh₃)₃I, polynuclear complexes [Cu_n(L-S,S′)_n] (4-6) were obtained. The structures of these compounds were investigated by IR, ¹H, ³¹P{¹H} NMR spectroscopy, ES-MS and elemental analyses. The crystal structures of Cu(PPh₃)₂L^b (2) and Cu(PPh₃)L^c (3) were determined by single-crystal X-ray diffraction.     

O-Alkylthio- and O-alkylselenooxalate iron complexes: Structures of CpFe(CO)2ECOCO2Me and [CpFe(CO)2ECO]2

When the iron sulfide complexes (μ-S_x)[CpFe(CO)₂]₂ (x = 2, 3) are treated with O-alkyl oxalyl chlorides ROCOCOCl the complexes CpFe(CO)₂SCOCO₂R (1) [R = Me (a), Et (b)] are obtained. Similarly, the complexes CpFe(CO)₂SeCOCO₂R (2) are obtained from the analogous iron selenide (μ-Se)[CpFe(CO)₂]₂ reaction with the same reagents. Treatment of the iron selenide with half equivalent of oxalyl chloride produces the dimeric complex [CpFe(CO)₂SeCO]₂ (3). The new complexes, 1, 2 and 3, have been characterized by elemental analyses, IR and ¹H NMR spectroscopy. The solid state structures of 1a, 2a, 3 and [CpFe(CO)₂SCO]₂ (4) were determined by an X-ray crystal structure analysis.     

The double-helicate terpyridine silver(I) compound [Ag2L2](SO3CF3)2 (L = 4′-phenyl-terpyridine) as a building block for di- and mononuclear complexes

The double-helicate dinuclear silver(I) complex [Ag₂L₂](SO₃CF₃)₂ (1) was obtained by reaction of AgSO₃CF₃ with 4′-phenyl-terpyridine (L). Each Ag⁺ ion is coordinated by two N-atoms from one of the ligands and by one N-atom of the other ligand, forming an irregular Ag₂N₆ bi-triangle geometry, with a metallic bond between the two silver ions. Complex 1 reacts with potentially bidentate ligands (L¹), such as 9,10-bis(diphenylphosphino)anthracene (PAnP), 4,4′-dipyridyl or bis(diphenyl phosphino)methane (DPPM), to give the corresponding dinuclear complexes with bridging L¹, [Ag₂L₂(μ-L¹)](SO₃CF₃)₂ (L¹ = PAnP 2, 4,4′-dipyridyl 3 or DPPM 4), whereas on reaction with PPh₃ forms the mononuclear complex [AgL(PPh₃)](SO₃CF₃) 5. Reaction of 1 with the potentially tridentate ligand tris(2-diphenylphosphinoethyl)amine (NP₃) results in complete decomposition of the coordination spheres to form [Ag(NP₃)](SO₃CF₃) 6. Compound 1 shows a strong fluorescence in the solid state with its excitation band at 383.5 nm, the emission band at 535.5 nm and the lifetime of 4.20 ns, but the derived complexes do not show fluorescent properties. The photoluminescence of 1 in various solvents was also studied. The complexes were characterized by ¹H NMR, elemental analysis, IR, MS, UV and single crystal X-ray diffraction.     

Synthesis of [SnPh2(SR)2] SR = SC6F4-4-H, SC6F5: Reactivity towards group 10 transition metal complexes

The organometallic tin(IV) complexes [SnPh₂(SR^F)₂] SR^F = ⁻SC₆F₄-4-H (1), ⁻SC₆F₅ (2), were synthesized and their reactivity with [MCl₂(PPh₃)₂] M = Ni, Pd and Pt explored. Thus, transmetallation products were obtained affording polymeric [Ni(SR^F)(μ-SR^F)]_n, monomeric cis-[Pt(PPh₃)₂(SC₆F₄-4-H)₂] (3) and cis-[Pt(PPh₃)₂(SC₆F₅)₂] (4) and dimeric species [Pd(PPh₃)(SC₆F₄-4-H)(μ-SC₆F₄-4-H)]₂ (5) and [Pd(PPh₃)(SC₆F₅)(μ-SC₆F₅)]₂ (6) for Ni, Pt and Pd, respectively. The crystal structures of complexes 1, 2, 3, 4 and 6 were determined.     

Spectral properties and bio-activity of copper(II) clofibriates, part III: crystal structure of Cu(clofibriate)2(2-pyridylmethanol)2, Cu(clofibriate)2(4-pyridylmethanol)2(H2O) dihydrate, and Cu2(clofibriate)4(N,N-diethylnicotinamide)2

New copper(II) clofibriates (clof, {2-(4-chlorophenoxy)-2-methylpropionic or 2-(4-chlorophenoxy)isobutyric acid}) of composition Cu(clof)₂L₂ (where L=2-pyridylmethanol (2-pymeth) (1), N-methylnicotinamide (Menia) (4), N,N-diethylnicotinamide (Et₂nia) (5), isonicotinamide (isonia) (7) or methyl-3-pyridylcarbamate (mpc) (8)), [Cu(clof)₂(4-pymeth)₂(H₂O)] · 2H₂O (4-pymeth=4-pyridylmethanol) (2 · 2H₂O) and Cu(clof)₂L (where L=4-pymeth (3) or Et₂nia (6)) have been prepared and spectroscopically characterized. All the Cu(clof)₂L₂ compounds seem to possess distorted octahedral copper(II) stereochemistry with differing tetragonal distortions. An X-ray analysis of 1 was carried out and it featured a tetragonal-bipyramidal geometry around the copper(II) atom. X-ray analysis of 2 · 2H₂O featured a square-pyramidal geometry around copper(II) atom. Both the Cu(clof)₂L compounds seem to consist of a binuclear unit of tetracarboxylate type bridging. An X-ray analysis of 6 revealed typical binuclear paddle-wheel type structure, consisting of two copper(II) atoms in square-pyramidal geometry bridged by four carboxylate anions in the xy-plane. All complexes under study were characterized by EPR and electronic spectroscopy. The antimicrobial effects have been tested on various strains of bacteria, yeasts and filamentous fungi.